Advisor- HEOR Oncology Research Scientist and Analyst

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Organization Overview

At Lilly, we unite caring with discovery to create medicines that make life better for people around the world, and Lilly Oncology has been delivering life-changing cancer medicines for more than 50 years. Our oncology pipeline is one of the largest in Lilly's history and spans targeted therapies, immunology, radioligand platforms, and cell therapy.

Position Summary

The demand for high quality health economic and outcomes research (HEOR) and real-world evidence (RWE) to support drug development, health technology assessment/access decisions, product differentiation, and clinical decision making continues to grow. The purpose of the Lilly Health Economic and Outcome Research team is to accelerate equitable patient access and transform healthcare delivery through the execution and communication of bold, high impact science.

The HEOR research scientist will provide strategic insight/leadership into the health outcomes (HO) evidence needs (e.g., health economics, patient reported outcomes, real world evidence, access and reimbursement) for Lilly’s portfolio.

The scientist will use their knowledge of health outcomes disciplines, therapeutic area knowledge of disease states in the Lilly portfolio, understanding of drug development and commercialization, and geographic